Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-12-11
pubmed:abstractText
Once familial medullary thyroid carcinoma gene carrier status is established, thyroidectomy must be performed in infancy for mutations in exon 10, but in familial medullary thyroid carcinoma with non-cysteine RET mutations, which is characterized by a late onset of C-cell disease, the appropriate timing of thyroidectomy is unclear.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0039-6060
pubmed:author
pubmed:issnType
Print
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1029-36; discussion 1036-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:14668737-Adolescent, pubmed-meshheading:14668737-Adult, pubmed-meshheading:14668737-Age Factors, pubmed-meshheading:14668737-Aged, pubmed-meshheading:14668737-Calcitonin, pubmed-meshheading:14668737-Carcinoma, Medullary, pubmed-meshheading:14668737-Child, pubmed-meshheading:14668737-Cysteine, pubmed-meshheading:14668737-Gastrointestinal Hormones, pubmed-meshheading:14668737-Heterozygote, pubmed-meshheading:14668737-Humans, pubmed-meshheading:14668737-Middle Aged, pubmed-meshheading:14668737-Mutation, pubmed-meshheading:14668737-Oncogene Proteins, pubmed-meshheading:14668737-Pentagastrin, pubmed-meshheading:14668737-Proto-Oncogene Proteins c-ret, pubmed-meshheading:14668737-Receptor Protein-Tyrosine Kinases, pubmed-meshheading:14668737-Thyroid Neoplasms, pubmed-meshheading:14668737-Thyroidectomy, pubmed-meshheading:14668737-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
pubmed:affiliation
Department of Endocrinology and Endocrine Surgery, CHU Timone, 254 rue St Pierre, F 13385 Marseille cedex 05, France.
pubmed:publicationType
Journal Article